Table 3.
HR and 95%CIs for the Association between Plasma Vitamin C Concentrations and Risk of Different Causes of Deaths in the Sub-cohort of Linxian General Population Nutrition Intervention Trial, China, 1999-2016
Causes of Deaths | Plasma vitamin C |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of cases | Quartilea, crude HRb | Quartilea, adjusted HRc | Continuousd | |||||||||
HR | 95% CI | Global Pe | Ptrendf | HR | 95% CI | Global Pe | Ptrendf | HR | 95% CI | |||
All deaths | Q1 | 170 | 1.00 | <0.0001 | <0.0001 | 1.00 | 0.04 | 0.006 | 0.90 | 0.82-0.99 | ||
Q2 | 139 | 0.79 | 0.63-0.99 | 0.91 | 0.73-1.14 | |||||||
Q3 | 125 | 0.65 | 0.52-0.82 | 0.76 | 0.60-0.96 | |||||||
Q4 | 117 | 0.60 | 0.48-0.76 | 0.75 | 0.59-0.95 | |||||||
Cancer | Q1 | 52 | 1.00 | 0.002 | 0.007 | 1.00 | 0.04 | 0.08 | 0.93 | 0.78-1.12 | ||
Q2 | 29 | 0.54 | 0.34-0.85 | 0.63 | 0.40-1.00 | |||||||
Q3 | 26 | 0.45 | 0.28-0.71 | 0.53 | 0.33-0.85 | |||||||
Q4 | 34 | 0.59 | 0.38-0.90 | 0.72 | 0.46-1.13 | |||||||
UGI cancer | Q1 | 37 | 1.00 | 0.0004 | 0.009 | 1.00 | 0.04 | 0.08 | 0.87 | 0.70-1.08 | ||
Q2 | 23 | 0.61 | 0.36-1.02 | 0.71 | 0.42-1.20 | |||||||
Q3 | 14 | 0.34 | 0.18-0.62 | 0.40 | 0.21-0.74 | |||||||
Q4 | 24 | 0.58 | 0.35-0.97 | 0.73 | 0.43-1.24 | |||||||
non-UGI Cancer | Q1 | 16 | 1.00 | 0.2 | 0.3 | 1.00 | 0.3 | 0.5 | 1.07 | 0.78-1.45 | ||
Q2 | 6 | 0.36 | 0.14-0.92 | 0.42 | 0.16-1.08 | |||||||
Q3 | 12 | 0.67 | 0.32-1.41 | 0.79 | 0.37-1.69 | |||||||
Q4 | 10 | 0.55 | 0.25-1.22 | 0.68 | 0.30-1.52 | |||||||
Stroke | Q1 | 51 | 1.00 | 0.1 | 0.02 | 1.00 | 0.5 | 0.2 | 0.91 | 0.77-1.08 | ||
Q2 | 42 | 0.81 | 0.54-1.22 | 0.93 | 0.62-1.41 | |||||||
Q3 | 45 | 0.79 | 0.53-1.18 | 0.92 | 0.61-1.38 | |||||||
Q4 | 32 | 0.57 | 0.37-0.89 | 0.72 | 0.46-1.13 | |||||||
Heart Diseases | Q1 | 50 | 1.00 | 0.03 | 0.003 | 1.00 | 0.1 | 0.03 | 0.83 | 0.71-0.98 | ||
Q2 | 50 | 0.96 | 0.65-1.41 | 1.09 | 0.74-1.62 | |||||||
Q3 | 41 | 0.72 | 0.48-1.09 | 0.80 | 0.53-1.22 | |||||||
Q4 | 33 | 0.54 | 0.35-0.85 | 0.65 | 0.41-1.02 | |||||||
Other | Q1 | 17 | 1.00 | 0.7 | 0.6 | 1.00 | 0.7 | 0.9 | 0.94 | 0.72-1.22 | ||
Q2 | 18 | 1.00 | 0.52-1.95 | 1.20 | 0.62-2.35 | |||||||
Q3 | 13 | 0.68 | 0.33-1.41 | 0.82 | 0.39-1.70 | |||||||
Q4 | 18 | 0.92 | 0.48-1.79 | 1.17 | 0.60-2.31 |
Abbreviation: UGI, upper gastrointestinal cancers including esophageal and gastric cancers.
Plasma Vitamin C quantile concentration (in μmol/L) of the sub-cohort by season-specific quartiles (winter/spring): Q1: <34.8/9.1; Q2: 34.8-51.5/9.1-16.8; Q3:51.5- 62.3/16.8-32.2; Q4: >62.3/32.2.
These models were adjusted for season of blood draw through stratification.
These models were adjusted for 4 age- / sex- subgroups, tobacco smoking, and season of blood draw through stratification.
Continuous, define as per 20 μmol/L increases, models were adjusted for 4 age- / sex- subgroups, tobacco smoking, and season of blood draw through stratification.
, Global P was derived from the 3 df test for the overall quartile Cox model.
, P for trend was derived from the models by assigning each person the ordinal value of the quartile.